HUP0101748A2 - Reboxetin alkalmazása idegrendszeri zavarok kezelésére szolgáló gyógyszerkészítmények előállítására - Google Patents

Reboxetin alkalmazása idegrendszeri zavarok kezelésére szolgáló gyógyszerkészítmények előállítására

Info

Publication number
HUP0101748A2
HUP0101748A2 HU0101748A HUP0101748A HUP0101748A2 HU P0101748 A2 HUP0101748 A2 HU P0101748A2 HU 0101748 A HU0101748 A HU 0101748A HU P0101748 A HUP0101748 A HU P0101748A HU P0101748 A2 HUP0101748 A2 HU P0101748A2
Authority
HU
Hungary
Prior art keywords
reboxetine
pharmaceutical compositions
compositions suitable
nervous disorders
producing pharmaceutical
Prior art date
Application number
HU0101748A
Other languages
English (en)
Inventor
Adriana Dubini
John Michael Mccall
Duncan Paul Taylor
Erik Ho Fong Wong
Philip F. Von Voigtlander
Original Assignee
Pharmacia & Upjohn S.P.A.
Pharmacia & Upjohn Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn S.P.A., Pharmacia & Upjohn Co. filed Critical Pharmacia & Upjohn S.P.A.
Publication of HUP0101748A2 publication Critical patent/HUP0101748A2/hu
Publication of HUP0101748A3 publication Critical patent/HUP0101748A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

57) A találmány tárgya reboxetin és származékai és/vagy gyógyászatilagelfogadható sói alkalmazása OCD, azaz kényszerképzet és pánikbetegség,azaz PD kezelésére alkalmas gyógyszer előállítására. Ó
HU0101748A 1998-04-13 1999-04-02 Use of reboxetine for producing pharmaceutical compositions suitable for treating nervous disorders HUP0101748A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8163298P 1998-04-13 1998-04-13
IT98MI000870 IT1305322B1 (it) 1998-04-23 1998-04-23 Uso di reboxetina per il trattamento di disturbi nervosi
US8503398P 1998-05-11 1998-05-11
PCT/US1999/004288 WO1999052518A2 (en) 1998-04-13 1999-04-02 New treatments for nervous disorders

Publications (2)

Publication Number Publication Date
HUP0101748A2 true HUP0101748A2 (hu) 2001-11-28
HUP0101748A3 HUP0101748A3 (en) 2001-12-28

Family

ID=11379879

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101748A HUP0101748A3 (en) 1998-04-13 1999-04-02 Use of reboxetine for producing pharmaceutical compositions suitable for treating nervous disorders

Country Status (25)

Country Link
US (1) US6391876B1 (hu)
EP (1) EP1071418B1 (hu)
JP (1) JP2002511408A (hu)
KR (1) KR100555279B1 (hu)
CN (1) CN1197569C (hu)
AT (1) ATE277617T1 (hu)
AU (1) AU755612B2 (hu)
BR (1) BR9909476A (hu)
CA (1) CA2320722A1 (hu)
DE (1) DE69920679T2 (hu)
DK (1) DK1071418T3 (hu)
EA (1) EA003546B1 (hu)
ES (1) ES2228035T3 (hu)
HU (1) HUP0101748A3 (hu)
IL (1) IL138887A0 (hu)
IT (1) IT1305322B1 (hu)
NO (1) NO20005131L (hu)
NZ (1) NZ507693A (hu)
PL (1) PL194039B1 (hu)
PT (1) PT1071418E (hu)
SI (1) SI1071418T1 (hu)
SK (1) SK14482000A3 (hu)
TR (1) TR200002970T2 (hu)
WO (1) WO1999052518A2 (hu)
ZA (1) ZA200004480B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500827B2 (en) * 1998-05-08 2002-12-31 Pharmacia & Upjohn Company Drug combinations
ES2246485T3 (es) 1999-07-01 2006-02-16 PHARMACIA & UPJOHN COMPANY LLC (s,s)-reboxetina para tratar la incontinencia.
EP1459751B1 (en) * 1999-07-01 2005-09-14 Pharmacia & Upjohn Company LLC (S,S)-reboxetine for treating migraine headaches
EA200300567A1 (ru) * 2000-11-15 2004-10-28 Эли Лилли Энд Компани Лечение состояний тревоги
PL375211A1 (en) * 2002-06-17 2005-11-28 Pharmacia Italia S.P.A. Pharmaceutical salts of reboxetine
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
GB2167407B (en) 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
JP2001520195A (ja) 1997-10-17 2001-10-30 イーライ・リリー・アンド・カンパニー 医薬の増強

Also Published As

Publication number Publication date
SI1071418T1 (en) 2005-04-30
CN1197569C (zh) 2005-04-20
EP1071418B1 (en) 2004-09-29
ITMI980870A1 (it) 1999-10-23
PT1071418E (pt) 2004-12-31
US6391876B1 (en) 2002-05-21
CA2320722A1 (en) 1999-10-21
NO20005131D0 (no) 2000-10-12
WO1999052518A2 (en) 1999-10-21
EA200001058A1 (ru) 2001-04-23
EP1071418A2 (en) 2001-01-31
DE69920679T2 (de) 2006-03-02
IL138887A0 (en) 2001-11-25
DK1071418T3 (da) 2005-01-03
AU3635199A (en) 1999-11-01
ZA200004480B (en) 2002-04-24
PL194039B1 (pl) 2007-04-30
ATE277617T1 (de) 2004-10-15
BR9909476A (pt) 2000-12-19
AU755612B2 (en) 2002-12-19
NO20005131L (no) 2000-10-12
JP2002511408A (ja) 2002-04-16
NZ507693A (en) 2003-08-29
ES2228035T3 (es) 2005-04-01
HUP0101748A3 (en) 2001-12-28
PL346294A1 (en) 2002-01-28
SK14482000A3 (sk) 2001-08-06
WO1999052518A3 (en) 1999-12-02
TR200002970T2 (tr) 2001-01-22
KR20010042641A (ko) 2001-05-25
CN1293569A (zh) 2001-05-02
EA003546B1 (ru) 2003-06-26
KR100555279B1 (ko) 2006-03-03
IT1305322B1 (it) 2001-05-04
DE69920679D1 (de) 2004-11-04

Similar Documents

Publication Publication Date Title
EA200601269A1 (ru) Лекарственное средство, содержащее производные фенилпиперазина
DE60216830D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen
DE60134453D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von ZNS und anderen Krankheiten
CY1105460T1 (el) Παραγωγα ακετυλενιου που εχουν mlgur 5 ανταγωνιστικη δραση
ATE492279T1 (de) Bupropinmetaboliten zur behandlung von dementia und anderen zerebrovasckulären erkrankungen
CA2534549A1 (en) Pteridine derivatives for the treatment of septic shock and tnf-.alpha.-related diseases.
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
HUP0202399A2 (hu) Dopamin D3 receptor ligandumok alkalmazása veseelégtelenség kezelésére szolgáló gyógyszerek előállítására
MY124786A (en) Bis-arylsulfones
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
WO1997005862A3 (en) Use of basic amino acids and derivatives for lowering ceramide levels
HUP0100080A2 (hu) Mirtazapin alkalmazása alvásiapnoe kezelésére szolgáló gyógyszerkészítmény előállítására
DE60014339D1 (de) Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren
HUP0101748A2 (hu) Reboxetin alkalmazása idegrendszeri zavarok kezelésére szolgáló gyógyszerkészítmények előállítására
BG105962A (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders
MXPA04001847A (es) Uso de sistemas de indan-1-ol polisbstituidos para producir drogas utilizadas en la profilaxis o tratamiento de la obesidad.
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
PT871446E (pt) Utilizacao de eliprodil para o fabrico de um medicamento destinado ao tratamento de perturbacoes isquemicas da retina ou do nervo optico
HUP0204391A2 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk
WO2000061125A3 (fr) L'osanetant dans le traitement des troubles de l'humeur
BR0115042A (pt) Ligandos de receptores de aminoalquilpirrolidina serotonina e composições, seus usos farmacêuticos, e processos para a sua sìntese
EP1632235A3 (en) Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders
DE69910242D1 (de) Verwendung eines Nikotin-Rezeptor Agonisten zur Herstellung eines Medikaments zur Behandlung von Zwangsneurosen

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees
NF4A Restoration of patent protection
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished